Important People and Places

Affiliations listed are those held at the approximate time characters appear in the book. Dates have been included for titles held by multiple characters. The names of some FDA divisions have since changed due to government reorganization.

DRUG COMPANIES

Ranbaxy

  MANAGING DIRECTORS

          Arun Sawhney, CEO and managing director, 2010–2015

          Atul Sobti, CEO and managing director, 2009–2010

          Malvinder Singh, CEO and managing director, 2006–2009

          Shivinder, brother

          Brian Tempest, CEO and managing director, 2004–2005

          Davinder Singh “D.S.” Brar, CEO and managing director, 1999–2004

          Parvinder Singh, chairman and managing director, 1992–1998; joint managing director, 1976–1991, with his father, Bhai Mohan

          Bhai Mohan Singh, chairman and joint managing director, 1976–1991; chairman and managing director, 1961–1975

RESEARCH AND DEVELOPMENT

   Rajinder “Raj” Kumar, director, 2004–2005

   Rashmi Barbhaiya, director, 2002–2004

   Rajiv Malik, head of formulation development and regulatory affairs

   Arun Kumar, associate director of regulatory affairs

   Dinesh Thakur, director and global head of research information & portfolio management

      Sonal Thakur, wife

      Andrew Beato, attorney at Stein, Mitchell, Muse & Cipollone LLP

U.S. BUSINESS

   Jay Deshmukh, senior vice president of global intellectual property

  Abha Pant, vice president of regulatory affairs

OUTSIDE LAWYERS AND CONSULTANTS

    Kate Beardsley, partner, Buc & Beardsley

    Christopher Mead, partner, London & Mead

    Warren Hamel, partner, Venable LLP

    Agnes Varis, consultant

Cipla Limited

      Yusuf “Yuku” Khwaja Hamied, chairman and managing director

      Khwaja Abdul “K.A.” Hamied, founder

Daiichi Sankyo Company

       Tsutomu Une, head of global strategy

Mylan N.V.

EXECUTIVES

       Heather Bresch, CEO

       Rajiv Malik, president

       Deborah Autor, senior vice president, head of global strategic quality

INDIAN GOVERNMENT

Central Drugs Standard Control Organization

       Gyanendra Nath “G.N.” Singh, drug controller general

Ministry of Health and Family Welfare

        Harsh Vardhan, minister

U.S. GOVERNMENT

Congress

        David Nelson, senior investigator, House Committee on Energy and Commerce

Food and Drug Administration

OFFICE OF THE COMMISSIONER

    Scott Gottlieb, commissioner, 2017–present

    Margaret Hamburg, commissioner, 2009–2015

OFFICE OF THE CHIEF COUNSEL

    Marci Norton, senior counsel

    Steven Tave, associate chief counsel for enforcement

CENTER FOR DRUG EVALUATION AND RESEARCH

    Janet Woodcock, director

   Robert Temple, deputy center director for clinical science

OFFICE OF COMPLIANCE

    Deborah Autor, director

    Thomas Cosgrove, director, Office of Manufacturing Quality

          Carmelo Rosa, director, Division of International Drug Quality

     Edwin Rivera-Martinez, chief, International Compliance Branch

          Douglas Campbell, compliance officer

          Karen Takahashi, compliance officer

OFFICE OF PHARMACEUTICAL SCIENCE

            Office of Generic Drugs

        Gary Buehler, director

OFFICE OF GLOBAL REGULATORY OPERATIONS & POLICY

            Office of International Programs

        FDA India Office

        Altaf Lal, director

        Atul Agrawal, supervisory consumer safety officer

        Muralidhara “Mike” Gavini, senior assistant country director

        Peter Baker, assistant country director

        Regina Brown, international program and policy analyst for drugs

        Office of Regulatory Affairs

      Dedicated Drug Team

         Jose Hernandez, investigator

      Office of Criminal Investigations

       Debbie Robertson, special agent

Department of Justice

    OFFICE OF CONSUMER LITIGATION

        Linda Marks, senior litigation counsel

    U.S. ATTORNEY’S OFFICE, DISTRICT OF MARYLAND

        Stuart Berman, assistant U.S. attorney

DOCTORS AND PATIENT ADVOCATES

     Joe Graedon, cohost of the NPR program The People’s Pharmacy

     William F. Haddad, generic drug advocate

     Harry Lever, director, Hypertrophic Cardiomyopathy Center, Cleveland Clinic

     Randall Starling, head, Section of Heart Failure and Cardiac Transplant Medicine, Cleveland Clinic

MANUFACTURING PLANTS

Fresenius Kabi

    Kalyani, Nadia District, West Bengal, eastern India

Mylan

    Morgantown, West Virginia, southeastern United States

    Nashik, Nashik District, Maharashtra, western India

Pfizer

    Dalian, Liaodong Peninsula, Liaoning Province, northeastern China

    Ringaskiddy, County Cork, southern Ireland

    Zhejiang Hisun (affiliate), Taizhou, Zhejiang, eastern China

Ranbaxy

    Dewas, Dewas District, Madhya Pradesh, central India

    Mohali, SAS Nagar District, Punjab, northern India

    Ohm Laboratories, New Brunswick, New Jersey, northeastern United States

    Paonta Sahib, Sirmour District, Himachal Pradesh, northern India

    Toansa, Nawanshahar District, Punjab, northern India

Wockhardt

     Chikalthana, Aurangabad District, Maharashtra, western India

     Waluj, Aurangabad District, Maharashtra, western India